Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Taylor

Showing results (661-670 of 697) with videos related to

Pageof 70
Sort By:
Plos One|November 5, 2010
A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosisJudith Field, Sharon R Browning, Laura J Johnson, et al.
NEJM Evidence|February 25, 2026
Multistate Infant Botulism Outbreak Associated with Powdered Infant FormulaConnie H Chung, Jason R Barash, Jacquelin L Castonguay, et al.
The Pharmacogenomics Journal|March 23, 2016
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association studyS Mahurkar, M Moldovan, V Suppiah, et al.
CNS Drugs|January 10, 2025
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic ApproachVivien Li, Fiona C McKay, David C Tscharke, et al.
Journal of Economic Entomology|September 13, 2022
Standardized Field Trials in Cotton and Bioassays to Evaluate Resistance of Tobacco Thrips (Thysanoptera: Thripidae) to Insecticides in the Southern United StatesJessica L Krob, Scott D Stewart, Sebe A Brown, et al.
Human Molecular Genetics|July 19, 2015
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosisBen J Gu, Judith Field, Sébastien Dutertre, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Tobacco Control|April 26, 2024
2020 design and methods of the Population Assessment of Tobacco and Health (PATH) study during the COVID-19 pandemicRalph DiGaetano, Sylvia Dohrmann, Ethel V Taylor, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Huntington'S Disease|September 4, 2023
Huntingtin Plays a Role in the Physiological Response to Ethanol in DrosophilaErin B D Clabough, Christia Aspili, William S Fussy, et al.
Pageof 70

Showing results (661-670 of 697) with videos related to

Sort By:
Pageof 70
Plos One|November 5, 2010
A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosisJudith Field, Sharon R Browning, Laura J Johnson, et al.
NEJM Evidence|February 25, 2026
Multistate Infant Botulism Outbreak Associated with Powdered Infant FormulaConnie H Chung, Jason R Barash, Jacquelin L Castonguay, et al.
The Pharmacogenomics Journal|March 23, 2016
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association studyS Mahurkar, M Moldovan, V Suppiah, et al.
CNS Drugs|January 10, 2025
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic ApproachVivien Li, Fiona C McKay, David C Tscharke, et al.
Journal of Economic Entomology|September 13, 2022
Standardized Field Trials in Cotton and Bioassays to Evaluate Resistance of Tobacco Thrips (Thysanoptera: Thripidae) to Insecticides in the Southern United StatesJessica L Krob, Scott D Stewart, Sebe A Brown, et al.
Human Molecular Genetics|July 19, 2015
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosisBen J Gu, Judith Field, Sébastien Dutertre, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Tobacco Control|April 26, 2024
2020 design and methods of the Population Assessment of Tobacco and Health (PATH) study during the COVID-19 pandemicRalph DiGaetano, Sylvia Dohrmann, Ethel V Taylor, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Huntington'S Disease|September 4, 2023
Huntingtin Plays a Role in the Physiological Response to Ethanol in DrosophilaErin B D Clabough, Christia Aspili, William S Fussy, et al.
Pageof 70